Progress in Cardiovascular Diseases (ISSN 0033-0620) is a prestigious international bimonthly journal published by Elsevier in the United States, dedicated to advancing the understanding of cardiovascular health through rigorous clinical and basic research. As a highly cited publication indexed in the Science Citation Index (SCI), the journal consistently maintains a high impact factor and is typically ranked in the top tiers of the Chinese Academy of Sciences (CAS) journal classification for medical sciences, underscoring its significant influence within the academic community. Its scope encompasses a broad spectrum of cardiovascular conditions, including hypertension, coronary artery disease, heart failure, and arrhythmias, with a particular emphasis on synthesizing frontier developments and publishing authoritative review articles that provide comprehensive insights into current medical knowledge. While the journal does not operate under an open access model, which may present accessibility considerations for some readers, it is renowned for its stringent peer-review process and high editorial standards, making it a vital resource for researchers, clinicians, and students seeking reliable, high-quality scholarship in the field of cardiovascular medicine.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com